Abbott Laboratories

ABTT34.SA·São Paulo·Healthcare
Compare
52.45+2.53 (+5.07%)today
At close: Nov 4, 4:10 PM BRT · May be delayed up to 15 min · BRL

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close49.92
Open0.00
Day range50.6652.56
52-week range0.0058.85
Off day high−0.21%
Off 52-week high−10.88%
Volume0.00
Avg. volume (3M)395
Market cap1.09T
EPS (TTM)1.17
Forward P/E—
P/E ratio (TTM)44.83
Dividend yield1.44% (0.7600)
Beta (5Y)0.54
Shares outstanding20.76B
Short interest—
Earnings dateJul 16, 2025
Analyst target—
Profit margin9.75%

Against its peers

Compare in full ›
ABTT34.SA ABBOTINDIA.NS LLY JNJ BMY INDSWFTLAB.NS
Market cap 1.09T 565.34B 1.26T 665.19B 131.21B 31.52B
P/E (TTM) 44.8 35.0 46.0 41.9 14.2 37.0
Forward P/E — 29.4 28.3 23.8 9.6 —
Price/book 1.4 11.8 31.4 8.2 5.6 2.1
Dividend yield 1.44% 1.94% 0.49% 1.94% 3.93% —
1-year change −5.67% −7.93% +51.26% +47.79% +37.66% +266.59%
Today +5.07% −1.90% +0.61% +3.81% +4.02% −3.72%

The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.

The Globe and Mail·Negative

Barclays Keeps Their Buy Rating on Abbott Laboratories (ABT)

In a report released today, Christopher Pasquale from Barclays maintained a Buy rating on Abbott Laboratories, with a price target of $120.00. According to TipRanks, Pasquale is a 4-star analyst with an average return of 9.7% and a 59.56%…

Seeking Alpha·

Abbott Laboratories: A New Growth Story Takes Shape

Abbott Laboratories remains a Buy, driven by robust device and diagnostics growth and the strategic spin-off of its Nutrition business. Learn more about ABT stock here. - Abbott Laboratories remains a Buy, driven by robust device and…

From the 4Search news index, newest first.

In the news

67mentions in 30 days
67with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 67 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance